Skip to content

WTO notification · TBT

CanadaUpdated: check whether it is now adopted or in force

Medicaments; – Canada

Official title

Notice of consultation: Proposed change to the veterinary omeprazole listing on the Prescription Drug List (2 pages, English and French) Consultation: Proposed change to the veterinary omeprazole listing on the Prescription Drug List (PDL) (1 page, English and French)

Canada issued an addendum on 4 November 2026 to the earlier TBT notification G/TBT/N/CAN/776. Addenda often report that a measure was adopted, changed, postponed or withdrawn. The measure was first notified on 18 May 2026. The comment period closed on 27 July 2026.

Expodite puts notifications like this one in your Updates centre, matched to the HS codes of your products and the markets you export to. Opens the requirements check for Canada and HS ⁨300490⁩ in your Expodite account.

Source: WTO ePing (opens in a new tab). Summaries by Expodite, which is independent of the WTO.

Published here:

Updated here:

At a glance

Products

Prescription status of medicinal ingredients for veterinary use (ICS: 11.220; HS 3004.90)

HS codes
  • 30 · Pharmaceutical products
    • 300490 Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses 'incl. those for transdermal…
Notifying member
Canada
Status
Updated: check whether it is now adopted or in force
Objectives
  • Other
Area
TBT: Technical product rulesTechnical barriers to trade
Notification type
Regular notification
Document symbol
G/TBT/N/CAN/776Latest notice: G/TBT/N/CAN/776/Add.1
Keywords
Human health

Key dates

Distributed by the WTO
Comment deadline
Closed on 27 July 2026
Proposed adoption
To be determined
Proposed entry into force
To be determined

How to comment

The comment period closed on 27 July 2026. You can still raise concerns about the measure with your country's WTO TBT enquiry point, quoting the document symbol G/TBT/N/CAN/776/Add.1; it can take them up with Canada.

Find your country's enquiry point on WTO ePing (opens in a new tab)

What the notification says

Latest notice (⁨G/TBT/N/CAN/776/Add.1⁩, 4 November 2026)

Notice of intent: Change to the veterinary omeprazole listing on the Prescription Drug List.

The purpose of this Notice of Intent is to announce that Health Canada will add a qualifier to the 'Omeprazole or its salts' listing on the veterinary use part of the Prescription Drug List on April 30, 2027. The intent is to allow for the non-prescription use of omeprazole when sold to prevent gastric ulcers in horses at a dosage of less than 2 mg/kg/day. Health Canada received a veterinary drug submission for an omeprazole product indicated to prevent gastric ulcers in horses at a dosage below 2 mg/kg/day. After reviewing the safety and efficacy information included in the submission, it was determined that omeprazole, when used for the noted purpose and at this dosage, does not meet the criteria for prescription status outlined in section C.01.040.3 of the Food and Drug Regulations. This amendment will be in effect on 30 April 2027 and will be communicated through the posting of a Notice of Amendment on the Health Canada website.

Health Canada is consulting Canadians on the proposal to allow certain veterinary drugs that contain omeprazole to be sold without a prescription. This consultation provides an opportunity to comment on a proposed change to the 'omeprazole or its salts' listing on the veterinary use part of the Prescription Drug List (PDL). The proposal applies only to the veterinary listing.

Notices on this measure

Every notice about this measure published here, newest first. Each one is the notifying member's own text.

  1. AddendumG/TBT/N/CAN/776/Add.1

    Notice of intent: Change to the veterinary omeprazole listing on the Prescription Drug List.

    The purpose of this Notice of Intent is to announce that Health Canada will add a qualifier to the 'Omeprazole or its salts' listing on the veterinary use part of the Prescription Drug List on April 30, 2027. The intent is to allow for the non-prescription use of omeprazole when sold to prevent gastric ulcers in horses at a dosage of less than 2 mg/kg/day. Health Canada received a veterinary drug submission for an omeprazole product indicated to prevent gastric ulcers in horses at a dosage below 2 mg/kg/day. After reviewing the safety and efficacy information included in the submission, it was determined that omeprazole, when used for the noted purpose and at this dosage, does not meet the criteria for prescription status outlined in section C.01.040.3 of the Food and Drug Regulations. This amendment will be in effect on 30 April 2027 and will be communicated through the posting of a Notice of Amendment on the Health Canada website.

  2. Regular notificationG/TBT/N/CAN/776

    Comment deadline: Closed on 27 July 2026

    Notice of consultation: Proposed change to the veterinary omeprazole listing on the Prescription Drug List (2 pages, English and French) Consultation: Proposed change to the veterinary omeprazole listing on the Prescription Drug List (PDL) (1 page, English and French)

    Health Canada is consulting Canadians on the proposal to allow certain veterinary drugs that contain omeprazole to be sold without a prescription. This consultation provides an opportunity to comment on a proposed change to the 'omeprazole or its salts' listing on the veterinary use part of the Prescription Drug List (PDL). The proposal applies only to the veterinary listing.

Sources

Expodite writes its summary from the official record. The notification and the documents it notifies are on the WTO's own websites.

All updates from Canada
  1. WTO notificationSPSProposed measure, not in force yet

    Proposal to modify two of the Lists of Permitted Food Additives (fruit and vegetable cellulose isolate); Proposal to modify the List of Permitted Food Enzymes (nuclease P1); and…

    Health Canada's Food and Nutrition Directorate completed premarket assessments of a number of food additive submissions seeking authorization for the use of: fruit and vegetable cellulose isolate as a stabilizing or thickening agent in cream for whipping at a maximum level of use of 2,000 ppm and…

    Symbol: G/SPS/N/CAN/1653

  2. WTO notificationSPSProposed measure, open for comments

    Modification to the List of Permitted Anticaking Agents (silicon dioxide)

    Health Canada's Food Directorate completed a premarket assessment of a food additive submission seeking authorization for the use of silicon dioxide as an anticaking agent in nutrient pre-mixes for use in infant formula. The outcome of the premarket assessment supports authorizing silicon dioxide…

    Symbol: G/SPS/N/CAN/1655Comments until 12 January 2027

  3. WTO notificationSPSProposed measure, not in force yet

    Proposal to modify the List of Permitted Food Additives with Other Purposes of Use (chloropentafluoroethane and octafluorocyclobutane)

    Health Canada has launched a consultation on a proposal to no longer allow chloropentafluoroethane and octafluorocyclobutane to be used as food additives by removing their respective entries from the List of Permitted Food Additives with Other Purposes of Use, as described in the notice. The…

    Symbol: G/SPS/N/CAN/1654

  4. WTO notificationTBTProposed measure, open for comments

    Regulations Amending the Clean Fuel Regulations (43 pages, available in English and French)

    The Clean Fuel Regulations (the Regulations) require regulated parties (producers and importers of gasoline or diesel) to reduce the lifecycle carbon intensity of the gasoline or diesel they produce or import for use in Canada. To achieve this, the Regulations establish annual lifecycle carbon…

    Symbol: G/TBT/N/CAN/785Comments until 14 January 2027

All export regulation updates

Get these automatically for your products and markets.

Expodite matches each notification to the markets you export to and the HS codes of your products, and puts the ones that concern you in your Updates centre, with the date comments close.